Assignee
DEKA BIOSCIENCES INC
US·24 granted patents·8 pending applications·252 citations·filing 2020–2024
Top patents by PatentIndex Score
32 records- 0198US12145007B2Dual cytokine fusion proteins comprising IL-10DEKA BIOSCIENCES INC·Filed 2023·Granted Nov 19, 2024·4 cites·4 claims
- 0298US12121755B2Dual cytokine fusion proteins comprising IL-10DEKA BIOSCIENCES INC·Filed 2023·Granted Oct 22, 2024·4 cites·4 claims
- 0398US12122814B2Dual cytokine fusion proteins comprising IL-10DEKA BIOSCIENCES INC·Filed 2023·Granted Oct 22, 2024·4 cites·4 claims
- 0498US12116392B2Dual cytokine fusion proteins comprising IL-10DEKA BIOSCIENCES INC·Filed 2023·Granted Oct 15, 2024·4 cites·4 claims
- 0598US12116390B2Dual cytokine fusion proteins comprising IL-10DEKA BIOSCIENCES INC·Filed 2023·Granted Oct 15, 2024·4 cites·4 claims
- 0698US12116389B2Dual cytokine fusion proteins comprising IL-10DEKA BIOSCIENCES INC·Filed 2023·Granted Oct 15, 2024·5 cites·4 claims
- 0798US12116391B2Dual cytokine fusion proteins comprising IL-10DEKA BIOSCIENCES INC·Filed 2023·Granted Oct 15, 2024·4 cites·4 claims
- 0898US12116393B2Dual cytokine fusion proteins comprising IL-10DEKA BIOSCIENCES INC·Filed 2023·Granted Oct 15, 2024·4 cites·6 claims
- 0998US12110317B2Dual cytokine fusion proteins comprising IL-10DEKA BIOSCIENCES INC·Filed 2023·Granted Oct 8, 2024·4 cites·4 claims
- 1098US12006346B2Dual cytokine fusion proteins comprising IL-10DEKA BIOSCIENCES INC·Filed 2023·Granted Jun 11, 2024·4 cites·4 claims
- 1198US11629178B2Dual cytokine fusion proteins comprising IL-10DEKA BIOSCIENCES INC·Filed 2022·Granted Apr 18, 2023·14 cites·6 claims
- 1298US11618775B2Dual cytokine fusion proteins comprising IL-10DEKA BIOSCIENCES INC·Filed 2022·Granted Apr 4, 2023·14 cites·6 claims
- 1398US11613563B2Dual cytokine fusion proteins comprising IL-10DEKA BIOSCIENCES INC·Filed 2022·Granted Mar 28, 2023·14 cites·6 claims
- 1498US11608368B2Dual cytokine fusion proteins comprising IL-10DEKA BIOSCIENCES INC·Filed 2022·Granted Mar 21, 2023·14 cites·4 claims
- 1598US11572397B2Dual cytokine fusion proteins comprising IL-10DEKA BIOSCIENCES INC·Filed 2022·Granted Feb 7, 2023·15 cites·6 claims
- 1698US11292822B2Dual cytokine fusion proteins comprising IL-10DEKA BIOSCIENCES INC·Filed 2021·Granted Apr 5, 2022·25 cites·6 claims
- 1798US10981965B2IL-10 variant molecules and methods of treating inflammatory diseaseDEKA BIOSCIENCES INC·Filed 2020·Granted Apr 20, 2021·25 cites·9 claims
- 1898US10981966B2IL-10 variant molecules conjugated with antibody variable domain regionsDEKA BIOSCIENCES INC·Filed 2020·Granted Apr 20, 2021·25 cites·13 claims
- 1998US10975133B2Methods for treating malignant tumors with IL-10 variant conjugatesDEKA BIOSCIENCES INC·Filed 2020·Granted Apr 13, 2021·22 cites·15 claims
- 2098US10975134B2Antibody-IL-10 fusion proteinsDEKA BIOSCIENCES INC·Filed 2020·Granted Apr 13, 2021·22 cites·10 claims
- 2198US10858412B2Antibody variable domain regions fused to IL-10 variant moleculesDEKA BIOSCIENCES INC·Filed 2020·Granted Dec 8, 2020·21 cites·11 claims
- 2294US2025135241A1Dual cytokine fusion proteins comprising il-10DEKA BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2389US2024294591A1Il-10 variant molecules and methods for treating inflammatory disease and oncologyDEKA BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2484US12268903B2Dual cytokine fusion proteins comprising IL-10DEKA BIOSCIENCES INC·Filed 2022·Granted Apr 8, 2025·0 cites·4 claims
- 2584US12263358B2Dual cytokine fusion proteins comprising IL-10DEKA BIOSCIENCES INC·Filed 2022·Granted Apr 1, 2025·0 cites·4 claims
- 2679US12552849B2Method of reducing bispecific t cell engager or chimeric antigen receptor t cell mediated cytokine release syndrome using interleukins-4, -10, or a fusion protein thereofDEKA BIOSCIENCES INC·Filed 2024·Granted Feb 17, 2026·0 cites·5 claims
- 2777US2022106373A1Il-10 variant molecules and methods for treating inflammatory disease and oncologyDEKA BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 2876US2024409600A1Dual cytokine fusion proteins comprising multi-subunit cytokinesDEKA BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2972US2023287075A1Dual cytokine fusion proteins comprising multi-subunit cytokinesDEKA BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 3072US2023340052A1Method of reducing bispecific t cell engager or chimeric antigen receptor t cell mediated cytokine release syndrome using interleukins-4, -10, or a fusion protein thereofDEKA BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3164US2023210953A1Use of dual cytokine fusion proteins comprising il-10 and adoptive cell therapies or bispecific t-cell engagers to treat cancerDEKA BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 3261US2021214782A1Method of using genetic markers, single nucleotide polymorphisms and/or indels to determine responsiveness to il-10 or il-10 derivative treatmentDEKA BIOSCIENCES INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →